These compounds may interact with:
Sphingosine 1-phosphate receptor 4
Potentially involved in: carcinoma; multiple sclerosis; diabetes mellitus, experimental; lung adenocarcinoma; psoriasis; relapsing remitting multiple sclerosis
Disease data sourced from Pharos.